Seralutinib blocks the activity of platelet-derived growth factor receptors (PDGFR), which play a crucial role in cell growth, angiogenesis, and tissue.
Molecular Weight
469.545
Molecular Formula
C27H27N5O3
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Applications
Seralutinib inhibits PDGFR, making it valuable in research aimed at developing treatments for diseases with disrupted PDGFR activity.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.
